[1]
“Incretin System: Recent Advances in Glucagon Like Peptide-1 and Dipeptidyl Peptidase-4 Inhibitors”, J Patan Acad Health Sci, vol. 1, no. 1, pp. 36–42, Jul. 2015, doi: 10.3126/jpahs.v1i1.13015.